Pharma Nordic ApS: Financial statements 2023
CVR: 37842338
Source: annual report 2023, Danish Business Authority
01/10/2022 – 30/09/2023
Pharma Nordic ApS (CVR 37842338) has filed annual accounts for 2023. In 2023, the company reported revenue of DKK 100,475 and a net result of DKK 55,130 compared with DKK -109,756 the year before. That is an increase of 92.1% compared with the year before. The profit margin was 54.9%. Equity in the 2023 report amounted to DKK -18,550.
- Revenue
- DKK 100,475
- Gross Profit
- DKK -117,480
- Profit/Loss
- DKK 55,130
- Equity
- DKK -18,550
- Total Assets
- DKK 1,304,938
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | 100 t. | -117 t. | 55 t. | -19 t. | - |
| 2022 | 52 t. | -108 t. | -110 t. | 876 t. | - |
| 2021 | 366 t. | 322 t. | 300 t. | 1 mio. | 0 |
| 2020 | 26 t. | -102 t. | -140 t. | 725 t. | - |
| 2018 | 42 t. | -42 t. | -64 t. | 644 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationAbout Pharma Nordic ApS
Pharma Nordic ApS is a Danish company of the type Anpartsselskab based in Skanderborg, founded in 2016. The company is registered under the industry Anden udlejning af boliger. The management consists of Niels Skovmand Juhl. The company is owned by Niels Skovmand Juhl, Christopher Skovmand Møller Juhl and Stephanie Skovmand Møller Juhl. According to the 2021 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK -5,137 the year before. Equity in the 2025 report amounted to DKK -23,687.